Trial of Cutaneous T-cell Lymphoma Therapy WP1220 Fully Enrolled
News
A Phase 2 clinical trial of WP1220, a potential topical treatment of cutaneous T-cell lymphoma (CTCL) lesions, has reached full patient enrollment. Developed by Moleculin Biotech, WP1220 is an inhibitor ... Read more